← BACK TO THE BLOG
THE PURE CRAFT JOURNAL

CBD Oil for Restless Legs Syndrome: Evidence, Mechanisms & Relief | PureCraft CBD

CBD Oil for Restless Legs Syndrome: Evidence, Mechanisms & Relief | PureCraft CBD

By PureCraft Editorial Team | PureCraft CBD | Updated October 2026

Restless legs syndrome (RLS) — officially known as Willis-Ekbom Disease — is one of the most underdiagnosed neurological conditions in the United States. Up to 10% of adults experience it, yet many go years without a proper diagnosis. If you've ever felt an irresistible urge to move your legs at night, accompanied by crawling, throbbing, or aching sensations that ease only when you get up and walk around, you know exactly how disruptive RLS can be. As interest in natural approaches grows, many people are asking whether CBD oil may offer any relief for restless legs syndrome. This guide explores the neuroscience, the evidence, and what CBD can and cannot realistically do for RLS.

What Is Restless Legs Syndrome? A Precise Definition

Restless legs syndrome is a neurological sensorimotor disorder classified by four core diagnostic criteria from the International Restless Legs Syndrome Study Group (IRLSSG):

  • Urge to move the legs — usually accompanied by uncomfortable or unpleasant sensations
  • Worsening at rest or inactivity — symptoms begin or worsen during periods of sitting or lying down
  • Partial or total relief with movement — walking, stretching, or leg movement alleviates symptoms
  • Circadian pattern — symptoms are exclusively or predominantly worse in the evening or night

The sensations people describe are uniquely uncomfortable: crawling, creeping, pulling, throbbing, aching, or itching — but crucially, these feelings originate inside the leg, not on the skin. This neurological origin distinguishes RLS from peripheral neuropathy, muscle cramps, or skin irritation.

RLS affects an estimated 5–10% of adults. Women are approximately twice as likely as men to develop the condition, and prevalence increases significantly with age. Despite its frequency, RLS remains highly underdiagnosed — many patients and even some clinicians dismiss the symptoms as ordinary restlessness, anxiety, or leg cramps.

Primary vs. Secondary RLS

Primary (idiopathic) RLS has a strong genetic component. It often begins before age 45, runs in families, and is not attributable to any identifiable underlying cause.

Secondary RLS is caused by an identifiable condition or medication, including:

  • Iron deficiency — the most common reversible cause; low ferritin is found in a significant proportion of RLS patients
  • Pregnancy — affects roughly 25% of pregnant women, particularly in the third trimester
  • Chronic kidney disease — end-stage renal disease carries a very high RLS prevalence
  • Medications — antihistamines, certain antidepressants (especially SSRIs and TCAs), antipsychotics, and antiemetics can trigger or significantly worsen RLS

Periodic Limb Movements of Sleep (PLMS)

Approximately 80% of RLS patients also experience Periodic Limb Movements of Sleep (PLMS) — involuntary, repetitive jerking or twitching of the legs during sleep that occurs every 20–40 seconds. PLMS causes sleep fragmentation even when the person has no conscious awareness of the movements. This makes the sleep disruption caused by RLS particularly complex: even when the uncomfortable leg sensations are managed, PLMS can independently degrade sleep quality.

The Dopamine Connection: Central to RLS Neuroscience

Why Dopamine Is at the Core of RLS

RLS is not simply a "leg problem." At its neurological root, RLS involves dysfunction of the dopaminergic system — specifically the nigrostriatal and spinal dopaminergic pathways — with a characteristic circadian pattern.

Circadian dopamine fluctuation: Dopamine synthesis and D2/D3 receptor sensitivity fluctuate throughout the day. Dopamine levels reach their lowest point in the late evening — precisely when RLS symptoms peak. This is why medications like levodopa and dopamine agonists (pramipexole, ropinirole) are so effective: they directly stimulate D2/D3 receptors, compensating for the evening dopamine trough.

The iron-dopamine link: Iron is a required cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. When body iron stores are low (reflected by low serum ferritin), dopamine production is impaired. This is why iron deficiency is such a significant contributor to secondary RLS, and why the ferritin threshold for RLS management (ideally >75 ng/mL) is higher than the general clinical threshold for iron deficiency anemia.

Spinal D3 receptors: Dopaminergic neurons in the spinal cord — particularly those acting on D3 receptors — normally modulate sensory processing and suppress inappropriate sensory signals from the legs. In RLS, dysfunction of these pathways leads to "disinhibition" of ascending sensory signals, producing the characteristic uncomfortable sensations.

CBD and Dopamine: An Important Distinction

CBD is not a direct dopamine agonist. It does not bind to D2 or D3 receptors the way pramipexole or ropinirole do. However, CBD has indirect dopaminergic effects through the endocannabinoid system (ECS): CB1 receptors in the striatum — part of the basal ganglia — modulate dopamine release. CBD's effects on anandamide (via FAAH inhibition) and on CB1 receptor signaling may have modest downstream effects on dopaminergic tone. But this is fundamentally different from the targeted dopaminergic mechanism of approved RLS medications, and this distinction matters when evaluating CBD's realistic role in RLS management.

How the Endocannabinoid System May Relate to RLS

The endocannabinoid system (ECS) is expressed throughout the central and peripheral nervous system, including in regions directly relevant to RLS. Understanding where CBD may interact with RLS mechanisms requires looking at several distinct pathways.

CB1 Receptors in the Basal Ganglia and Spinal Cord

CB1 receptors are densely expressed in the basal ganglia — the brain region that orchestrates motor control and is central to dopaminergic regulation. The ECS acts as a modulatory system here, influencing dopamine release and sensory gating. In the spinal cord, CB1 receptors participate in modulating ascending sensory signals. Retrograde endocannabinoid signaling (where 2-arachidonoylglycerol, or 2-AG, is released from postsynaptic neurons to inhibit presynaptic activity) can dampen exaggerated sensory input — potentially relevant to the disinhibited sensory pathways in RLS.

Anandamide, FAAH, and Sensory Processing

One of CBD's best-characterized mechanisms is inhibition of fatty acid amide hydrolase (FAAH), the enzyme that breaks down anandamide. By slowing anandamide degradation, CBD increases endocannabinoid tone. Anandamide is a partial agonist at TRPV1 (transient receptor potential vanilloid 1) channels — sensory receptors found in peripheral nerves throughout the legs and skin. At higher concentrations, anandamide actually desensitizes TRPV1, reducing its sensitivity. TRPV1 desensitization may blunt the hypersensitized sensory signaling that contributes to the uncomfortable leg sensations in RLS. This is the same pathway relevant to CBD's potential role in pain.

Anti-Inflammatory Effects via CB2

CB2 receptors are expressed primarily in immune cells and peripheral tissues. Their activation reduces neuroinflammatory signaling — relevant to secondary RLS, particularly when inflammation may be contributing to peripheral sensitization. CBD's indirect CB2 effects (and its various non-ECS anti-inflammatory mechanisms) align with research on CBD oil for inflammation, though direct RLS-specific anti-inflammatory data are lacking.

Sleep Quality and the RLS Cycle

RLS and sleep disruption form a feedback cycle: RLS impairs sleep, and sleep deprivation lowers pain thresholds and may worsen neurological symptom severity. By addressing CBD oil's effects on insomnia and sleep architecture, CBD may help break this cycle. Research by Shannon et al. (2019) found that CBD supplementation was associated with improved sleep scores in anxiety-related sleep disturbance — though RLS-specific sleep data remain limited.

5-HT1A and the SSRI Complication

CBD is a partial agonist at 5-HT1A (serotonin) receptors. This is notable in the RLS context because SSRIs — which increase serotonergic tone — are a well-established trigger for worsening RLS symptoms. CBD's 5-HT1A activity is complex: it may provide anxiolytic effects (relevant to RLS-related anxiety and hyperarousal at bedtime), but its net interaction with serotonergic signaling in RLS patients, particularly those on SSRIs, is not well characterized. Patients taking SSRIs who are experiencing worsened RLS should discuss this medication effect with their prescriber before adding any supplement, including CBD.

Topical CBD: A Distinct Approach for Leg-Specific Relief

One of the most compelling and underappreciated applications for CBD oil in RLS is topical delivery — applying CBD directly to the affected legs. PureCraft's CBD Muscle and Joint Cream deserves specific attention in the RLS context for several reasons.

Why Topical CBD May Help with Restless Legs

Peripheral CB1/CB2 receptors: CB1 and CB2 receptors are expressed in peripheral nerve fibers and skin. Topical CBD applied to the legs may interact with these receptors locally, modulating peripheral sensory signaling without significant systemic absorption.

TRPV1 desensitization in peripheral nerves: The same TRPV1 mechanism described above for systemic CBD applies peripherally. CBD applied topically to the legs may desensitize TRPV1 channels in the cutaneous nerve endings and deep tissue, potentially modulating the uncomfortable sensory signals that characterize RLS.

Application timing: Applying CBD cream to the calves, shins, and thighs 30–60 minutes before typical evening symptom onset — or at the first sign of RLS symptoms — may provide localized relief during the critical pre-sleep window.

Nanoemulsion technology: Standard topical CBD absorption through intact skin is generally modest. PureCraft's nanoemulsion-based cream uses nano-sized CBD particles that may enhance skin penetration and bioavailability compared to conventional cream formulations.

The combination approach: The most comprehensive strategy may combine oral CBD (for central/systemic ECS effects) with topical application (for peripheral/local effects). Oral CBD addresses the central sensory processing dysfunction; topical CBD addresses the peripheral sensory signals from the legs themselves.

Evidence Comparison: RLS Treatments Ranked Honestly

Transparency about evidence quality is essential. Here is an honest comparison of established and emerging RLS interventions:

Treatment Evidence Level Mechanism Notes
Dopamine agonists (pramipexole, ropinirole) HIGH (FDA-approved) D2/D3 receptor agonism Augmentation risk with long-term use
Iron supplementation (iron-deficient RLS) HIGH Restores dopamine synthesis cofactor Check ferritin first; target >75 ng/mL
Gabapentin / Pregabalin HIGH (FDA-approved) Alpha-2-delta calcium channels Better for painful RLS variants
Low-dose opioids MODERATE Opioid receptors Reserved for refractory RLS only
CBD oil (oral) LOW-MODERATE ECS modulation, indirect dopamine, anti-inflammatory Promising; limited RLS-specific RCT data
CBD (topical) LOW Peripheral CB1/CB2, TRPV1 Anecdotal; mechanistically plausible
Lifestyle (iron-rich diet, exercise, reduced alcohol/caffeine) MODERATE Multiple pathways First-line adjuncts; always appropriate

Dopamine Augmentation: What RLS Patients Need to Know

Important Warning: Dopamine Augmentation

Long-term use of dopamine agonists for RLS carries the risk of augmentation — a paradoxical worsening and expansion of RLS symptoms over time. With augmentation, symptoms may begin earlier in the day, spread to the arms or trunk, and intensify. Many patients seeking alternatives to dopamine agonists, including CBD, are doing so because of augmentation. While CBD has not been established as an augmentation treatment, it may serve as an adjunct to help manage symptoms. Critically: never discontinue dopamine agonists abruptly without medical supervision. Withdrawal from pramipexole or ropinirole can cause a severe rebound syndrome. Work with your prescriber on any medication changes.

CBD Oil for RLS: Drug Interaction Considerations

RLS patients are often on multiple medications. CBD is metabolized primarily by the CYP450 enzyme system — particularly CYP2C19, CYP3A4, and CYP2D6 — and can alter the plasma concentrations of other drugs processed by these enzymes. For a full overview, see our guide on CBD oil drug interactions. For RLS specifically:

Medication Interaction Risk Notes
Pramipexole / Ropinirole LOW-MODERATE Minor CYP1A2/CYP3A4 involvement; possible additive hypotension. Monitor blood pressure.
Gabapentin MODERATE Additive CNS sedation. May enhance sleep benefits but increase daytime drowsiness at higher doses.
Pregabalin MODERATE Similar to gabapentin; additive CNS depression. Use caution; start CBD at low doses.
Iron supplements (ferrous sulfate) SAFE No pharmacological interaction known. Can take together; iron repletion addresses root cause in iron-deficient RLS.
SSRIs (e.g., sertraline, escitalopram) MODERATE CYP2C19/CYP2D6 interaction may alter SSRI levels. Also: SSRIs are a known RLS trigger — discuss with prescriber.
Opioids (refractory RLS) HIGH Significant additive CNS and respiratory depression risk. Do not combine without close medical supervision.

Secondary RLS: How CBD Fits (and Doesn't Fit) by Cause

Iron Deficiency RLS

If your RLS is driven by iron deficiency (check serum ferritin; target >75 ng/mL), CBD cannot replace iron supplementation — only restoring iron stores will address the root cause by enabling normal dopamine synthesis. However, CBD may offer adjunctive symptom management during the weeks it takes for iron repletion to improve RLS.

Pregnancy RLS

RLS affects roughly one in four pregnant women, often emerging in the third trimester. CBD is not recommended during pregnancy. Iron and folate supplementation, gentle stretching, and sleep positioning adjustments are the appropriate approaches. For sleep support, see our guide to CBD oil for sleep — but consult your OB before any supplement use during pregnancy.

SSRI-Induced RLS

If an SSRI or antidepressant appears to have triggered or worsened your RLS, the appropriate first step is discussing the medication with your prescriber — not adding supplements. CBD's complex 5-HT1A activity may partially offset some serotonergic effects, but this has not been studied in SSRI-induced RLS specifically, and CBD can also alter SSRI blood levels via CYP enzyme interactions.

Renal Disease RLS

Patients with chronic kidney disease who experience RLS should exercise particular caution with CBD: renal impairment can affect drug metabolism and clearance, and the safety of CBD in advanced kidney disease has not been adequately studied. Consult a nephrologist before adding any CBD product.

PureCraft CBD Products for Restless Legs: A Strategic Approach

Given the unique dual nature of RLS — a central neurological dysfunction and a peripheral sensory experience — a combination oral + topical strategy may be the most comprehensive approach. Understanding CBD oil dosage is essential before starting any regimen.

Recommended Product Strategy for RLS

Primary (Topical — Featured):
CBD Muscle and Joint Cream — Apply generously to calves, shins, and thighs 30–60 minutes before typical evening RLS symptom onset, or at the first sign of discomfort. The nanoemulsion formula enhances skin penetration. This addresses peripheral sensory signaling directly in the affected area.

Sleep Support:
CBD+CBN+Melatonin Gummies — Taken 60–90 minutes before bed. The combination of CBD, CBN (a mildly sedating cannabinoid), and melatonin addresses RLS-associated sleep onset difficulty from multiple angles. For patients whose primary complaint is the sleep disruption caused by RLS, this is a logical choice.

Systemic Evening Dose:
Broad Spectrum CBD Oil — An evening sublingual dose for systemic ECS support and anxiolytic effects, addressing the hyperarousal and anxiety that often accompany RLS at bedtime. Sublingual delivery provides faster onset than capsules — relevant when timing around symptom onset matters.

Daily Baseline:
Broad Spectrum Softgels — Consistent daily dosing maintains baseline ECS tone. The water-soluble nanoemulsion format in the softgels provides enhanced bioavailability compared to standard oil-based capsules.

Flexible Evening Option:
Broad Spectrum Gummies or Full Spectrum Berry Gummies — A convenient pre-sleep dose for those who prefer gummies. Full spectrum includes trace THC alongside CBD and other cannabinoids, which some people find more effective for pain and sleep via the entourage effect.

What the Research Says: Key Studies

Direct clinical research on CBD oil specifically for RLS is limited. The evidence base draws on studies of CBD's relevant mechanisms — anxiety, pain, sleep, and neurological symptoms. For detailed context on what CBD oil is and how it works, see our foundational guide.

Blessing et al. (2015) (PMID 26341731) conducted a comprehensive review of CBD as a potential treatment for anxiety disorders, establishing CBD's effects on 5-HT1A receptors and the ECS as relevant to neurological and sensory symptom management.

Shannon et al. (2019) (PMID 30624194) found in a retrospective case series that CBD was associated with improved sleep scores in 66.7% of patients in the first month, with the primary indication being anxiety — suggesting relevance to RLS patients whose sleep is disrupted by both anxiety and leg sensations.

Russo (2016) (PMID 28861491) described the clinical endocannabinoid deficiency hypothesis, proposing that dysregulation of the ECS underlies certain neurological conditions including those with pain and sensory processing abnormalities — a framework that may provide theoretical grounding for CBD's relevance to RLS.

Crippa et al. (2011) (PMID 20829306) demonstrated CBD's anxiolytic effects via 5-HT1A receptors in neuroimaging studies — relevant to the anxiety and hyperarousal component of RLS at bedtime.

Corroon & Phillips (2018) (PMID 30014049) surveyed CBD users and found that sleep and pain were among the most common reasons for CBD use, with the majority reporting it as effective — though this is survey data, not a controlled trial.

Capano et al. (2020) (PMID 31711352) found in a randomized controlled study that full-spectrum CBD oil significantly reduced opioid use and improved chronic pain and sleep quality in patients with chronic pain conditions — suggesting a potential role in refractory RLS patients where pain and sleep are primary concerns.

For a broader look at CBD oil for chronic pain and CBD oil for muscle recovery, those guides explore the anxiolytic and musculoskeletal mechanisms in more detail.

Frequently Asked Questions: CBD Oil for Restless Legs Syndrome

Does CBD oil help with restless legs syndrome?

CBD oil may help some people with restless legs syndrome, but the evidence is indirect rather than from RLS-specific trials. CBD's potential mechanisms — ECS modulation in the basal ganglia and spinal cord, TRPV1 desensitization, anti-inflammatory effects, and sleep quality improvement — are plausible for RLS symptom management. However, CBD is not a direct dopamine agonist and does not address the core dopaminergic dysfunction driving RLS the way pramipexole or ropinirole do. Most clinical experience comes from anecdotal reports and surveys of CBD users rather than controlled trials. For patients looking for adjunctive support alongside conventional treatment, or those seeking natural options for mild-to-moderate symptoms, CBD oil is worth discussing with a healthcare provider.

Why do my legs feel better when I rub CBD cream on them?

There are several plausible mechanisms. First, CBD cream contains CBD that may interact with CB1 and CB2 receptors in the skin and peripheral nerve fibers, modulating local sensory signaling. Second, CBD can desensitize TRPV1 channels — sensory receptors in peripheral nerves — potentially blunting the uncomfortable sensations characteristic of RLS. Third, the physical act of massaging the cream into the legs stimulates mechanoreceptors, activates proprioception, and increases local circulation — all of which can temporarily relieve RLS symptoms through non-CBD mechanisms. The combination of physical massage and CBD's peripheral actions may explain why many people find topical application genuinely helpful during symptom flares.

What's the best CBD oil dosage for restless legs?

No established clinical dosage exists specifically for RLS because RLS-specific CBD trials are lacking. Based on the broader CBD dosage literature and the mechanisms relevant to RLS (pain, anxiety, sleep), a common starting point is 15–25mg of CBD taken in the evening, 60–90 minutes before the typical onset of symptoms or before bedtime. Some people use a smaller dose (10–15mg) in the late afternoon as well, given that RLS symptoms can begin before nightfall. Topically, apply a generous amount of CBD cream 30–60 minutes before expected symptom onset. Our comprehensive CBD dosage guide covers titration principles in detail. The key rule: start low, go slow, and adjust based on response over 2–4 weeks.

Can CBD oil replace pramipexole or ropinirole for RLS?

No — at least not based on current evidence. Pramipexole and ropinirole are FDA-approved RLS treatments with large clinical trials demonstrating their efficacy. They directly stimulate the D2 and D3 dopamine receptors that are dysfunctional in RLS. CBD has no established equivalent mechanism. For patients with moderate-to-severe RLS, replacing dopamine agonists with CBD would be premature and potentially harmful — particularly given the risk of severe rebound symptoms if dopamine agonists are discontinued abruptly. Where CBD may have a realistic role is as an adjunct: supporting sleep, managing anxiety around bedtime, and potentially providing topical peripheral relief, while conventional treatment addresses the core neurological dysfunction. Patients with dopamine augmentation who are being transitioned off dopamine agonists under medical supervision might consider CBD as a supportive measure — but only in coordination with their prescriber.

Does CBD oil help with the sleep problems caused by restless legs?

This is arguably where CBD oil has its strongest rationale in the RLS context. RLS-associated sleep disruption involves multiple compounding factors: the physical discomfort that delays sleep onset, the anxiety and hyperarousal of anticipating symptoms, and (in 80% of patients) PLMS-driven sleep fragmentation. CBD may address at least the first two: Shannon et al. (2019) found CBD improved sleep scores in the majority of patients studied, and CBD's 5-HT1A anxiolytic activity addresses pre-sleep anxiety. The CBD+CBN+Melatonin Gummies combine CBD with CBN (which may have sedative properties) and melatonin (which addresses circadian rhythm alignment), creating a multi-mechanism approach to RLS-related insomnia. PLMS itself (the involuntary limb movements during sleep) is less likely to be addressed by CBD, as this requires treatment of the underlying RLS neurological process.

Can CBD oil make restless legs worse?

CBD oil is generally not expected to worsen RLS. However, there are some nuances worth knowing. SSRIs are a documented RLS trigger, and CBD has serotonergic activity (5-HT1A partial agonism) — though CBD's 5-HT1A effects are thought to be anxiolytic rather than pro-serotonergic in the way SSRIs are, and direct worsening of RLS via CBD's 5-HT1A activity has not been reported. A more practical concern: sedating CBD products taken too early in the day could theoretically reduce activity levels (since movement relieves RLS), but evening dosing timed appropriately does not pose this issue. The key watchout is for patients on SSRIs, where the interaction between CBD and the SSRI (including potential changes in SSRI plasma levels via CYP enzyme competition) should be reviewed with a prescriber. In general, CBD at standard doses does not appear to have RLS-worsening properties.

Is CBD oil safe to take with gabapentin for RLS?

CBD oil and gabapentin can both be sedating, and their CNS-depressant effects are additive. This means the combination may enhance sleep benefits — which could be desirable for RLS patients — but also increases the risk of daytime drowsiness, cognitive blunting, and dizziness, particularly at higher doses of either. For RLS patients taking gabapentin or pregabalin, starting CBD at a low dose (10–15mg) in the evening and slowly titrating up over 2–3 weeks is the safest approach. Taking both in the evening rather than during the day reduces the impact on daytime function. Always inform your prescriber when adding CBD to a gabapentin regimen.

Does CBD oil help with leg cramps vs. restless legs?

These are distinct conditions with different mechanisms, and it is worth distinguishing them clearly. Leg cramps (nocturnal leg cramps) are sudden, involuntary muscle contractions — usually in the calf — that are painful and visible as muscle spasms. They typically resolve within seconds to minutes with stretching. Restless legs syndrome, by contrast, involves uncomfortable sensory experiences deep inside the leg (crawling, aching, pulling) without visible muscle contraction, driven by neurological (dopaminergic) dysfunction. CBD's muscle-related effects — potentially reducing muscle tension via indirect mechanisms — might be more relevant to leg cramps, where the topical cream applied to cramping muscles could help. For true RLS, the neurological mechanisms (ECS, TRPV1, indirect dopaminergic) are more relevant than muscle relaxation per se. Magnesium deficiency is a common cause of nocturnal leg cramps; if you are experiencing painful muscle spasms rather than the sensory-urge pattern of RLS, checking magnesium levels is worth discussing with your doctor.

Can CBD oil help with periodic limb movements during sleep?

Periodic Limb Movements of Sleep (PLMS) — the involuntary leg jerking that occurs every 20–40 seconds during sleep in ~80% of RLS patients — is a distinct phenomenon from the conscious uncomfortable sensations of RLS. PLMS is driven by the same underlying spinal dopaminergic dysregulation and responds to the same dopaminergic treatments. There is no established evidence that CBD oil reduces PLMS frequency or index. However, PLMS causes sleep fragmentation even without the patient being aware of the movements, and CBD's sleep-supporting effects (reduced sleep latency, possible improvement in sleep architecture) may partially offset the subjective sleep quality impact — even if the limb movements themselves are not reduced. A sleep study (polysomnography) is needed to formally assess PLMS. If PLMS is significantly disrupting sleep quality despite managed daytime RLS symptoms, discuss this specifically with your neurologist or sleep specialist.

How long does CBD oil take to work for restless legs?

The timeline depends on the delivery format and the symptom being addressed. Sublingual CBD oil held under the tongue is absorbed through the oral mucosa and takes effect in 15–45 minutes — useful for same-evening symptom management. Gummies and softgels are digested first, with effects beginning in 30–90 minutes and lasting longer. Topical cream applied to the legs may provide localized relief within 20–45 minutes. For longer-term systemic benefits — ECS tone regulation, improved baseline sleep quality, reduced anxiety — allow 2–4 weeks of consistent daily use before assessing effectiveness. The ECS adapts gradually, and RLS severity naturally fluctuates, so short-term trials of a few days are insufficient to evaluate CBD's real impact on this condition.

Related Articles

References

  1. Blessing EM, et al. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825-836. PMID: 26341731
  2. Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm J. 2019;23:18-041. PMID: 30624194
  3. Russo EB. Clinical Endocannabinoid Deficiency Reconsidered. Cannabis Cannabinoid Res. 2016;1(1):154-165. PMID: 28861491
  4. Crippa JA, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder. J Psychopharmacol. 2011;25(1):121-130. PMID: 20829306
  5. Corroon J & Phillips JA. A Cross-Sectional Study of Cannabidiol Users. Cannabis Cannabinoid Res. 2018;3(1):152-161. PMID: 30014049
  6. Capano A, et al. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients. Postgrad Med. 2020;132(1):56-61. PMID: 31711352

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. CBD products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or condition, including restless legs syndrome. RLS is a neurological condition that may require medical diagnosis and treatment. Do not discontinue prescribed medications without consulting your healthcare provider. If you experience persistent uncomfortable leg sensations or sleep disruption, please consult a qualified healthcare professional. Individual results vary.